- Home
- AII vs CMPS Comparison
AII vs CMPS Comparison
Compare AII & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AII
- CMPS
- Stock Information
- Founded
- AII 2006
- CMPS 2020
- Country
- AII United States
- CMPS United Kingdom
- Employees
- AII N/A
- CMPS N/A
- Industry
- AII Property-Casualty Insurers
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- AII Finance
- CMPS Health Care
- Exchange
- AII Nasdaq
- CMPS Nasdaq
- Market Cap
- AII 323.7M
- CMPS 364.9M
- IPO Year
- AII 2025
- CMPS 2020
- Fundamental
- Price
- AII $17.86
- CMPS $2.53
- Analyst Decision
- AII Buy
- CMPS Strong Buy
- Analyst Count
- AII 3
- CMPS 7
- Target Price
- AII $21.50
- CMPS $17.83
- AVG Volume (30 Days)
- AII 174.7K
- CMPS 3.9M
- Earning Date
- AII 01-01-0001
- CMPS 07-31-2025
- Dividend Yield
- AII N/A
- CMPS N/A
- EPS Growth
- AII N/A
- CMPS N/A
- EPS
- AII 3.19
- CMPS N/A
- Revenue
- AII $231,932,000.00
- CMPS N/A
- Revenue This Year
- AII $25.17
- CMPS N/A
- Revenue Next Year
- AII $34.03
- CMPS N/A
- P/E Ratio
- AII $5.54
- CMPS N/A
- Revenue Growth
- AII 1.73
- CMPS N/A
- 52 Week Low
- AII $15.78
- CMPS $2.25
- 52 Week High
- AII $19.45
- CMPS $8.54
- Technical
- Relative Strength Index (RSI)
- AII N/A
- CMPS 29.52
- Support Level
- AII N/A
- CMPS $2.25
- Resistance Level
- AII N/A
- CMPS $5.15
- Average True Range (ATR)
- AII 0.00
- CMPS 0.41
- MACD
- AII 0.00
- CMPS -0.24
- Stochastic Oscillator
- AII 0.00
- CMPS 9.66
About AII American Integrity Insurance Group Inc. Common Stock
American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.